Quốc gia: Ai-len
Ngôn ngữ: Tiếng Anh
Nguồn: HPRA (Health Products Regulatory Authority)
Tramadol hydrochloride; Dexketoprofen
Menarini International Operations Luxembourg S.A.
N02AJ; N02AJ14
Tramadol hydrochloride; Dexketoprofen
75mg/25 milligram(s)
Granules for oral solution in sachet
Product subject to prescription which may not be renewed (A)
Opioids in combination with non-opioid analgesics; tramadol and dexketoprofen
Not marketed
2018-04-06
1 PACKAGE LEAFLET: INFORMATION FOR THE USER SKUDEXA 75 MG/25 MG FILM-COATED TABLETS _ _ tramadol hydrochloride/dexketoprofen READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Skudexa is and what it is used for 2. What you need to know before you take Skudexa 3. How to take Skudexa 4. Possible side effects 5. How to store Skudexa 6. Contents of the pack and other information 1. WHAT SKUDEXA IS AND WHAT IT IS USED FOR Skudexa contains the active substances tramadol hydrochloride and dexketoprofen. Tramadol hydrochloride is a pain killer belonging to a group of medicines called opioids that act on the central nervous system. It relieves pain by acting on specific nerve cells of the brain and spinal cord. Dexketoprofen is a pain killer and it belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). Skudexa is used for the symptomatic short term treatment of moderate to severe acute pain in adults. You must talk to a doctor if you do not feel better or if you feel worse. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE SKUDEXA DO NOT TAKE SKUDEXA: • if you are allergic to dexketoprofen, to tramadol hydrochloride or any of the other ingredients of this medicine (listed in section 6) • if you are allergic to acetylsalicylic acid or to other NSAIDs • if you have suffered attacks of asthma, acute allergic rhinitis (a short period of inflamed lining of the nose), nasal polyps (lumps in the nose due to allergy), urticaria (skin rash), angioedema (swollen face, eyes, lips, or tongue, or respiratory di Đọc toàn bộ tài liệu
Health Products Regulatory Authority 09 January 2023 CRN00D9DD Page 1 of 18 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Skudexa 75 mg/25 mg granules for oral solution in sachet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains: 75 mg of tramadol hydrochloride and 25 mg of dexketoprofen (as dexketoprofen trometamol). Excipient(s) with known effect: sucrose 2.7 g per sachet. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Granules for oral solution in sachet. The granules are white to almost white. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Symptomatic short term treatment of moderate to severe acute pain in adult patients whose pain is considered to require a combination of tramadol and dexketoprofen. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The recommended dosage is one sachet (corresponding to 75 mg of tramadol hydrochloride and 25 mg of dexketoprofen). Additional doses can be taken as needed, with a minimum dosing interval of 8 hours. The total daily dose should not exceed three sachets per day (corresponding to 225 mg of tramadol hydrochloride and 75 mg of dexketoprofen). Skudexa is intended for short term use only and the treatment must be strictly limited to the symptomatic period and in any case not more than 5 days. Switching to a single agent analgesia should be considered according to pain intensity and response of the patient. Undesirable effects may be minimised by using the lowest number of doses for the shortest duration necessary to control symptoms (see section 4.4). _Elderly:_ In elderly patients the starting recommended dosage is one sachet; additional doses can be taken as needed with the minimum dose interval of 8 hours and not exceeding the total daily dose of 2 sachets (corresponding to 150 mg of tramadol hydrochloride and 50 mg of dexketoprofen). The dosage may be increased to a maximum of 3 sachets as recommended for the general population only after good general tolerance has been ascertained. Limited data are a Đọc toàn bộ tài liệu